Ophthalmic Image Synthesis and Analysis with Generative Adversarial Network Artificial Intelligence
Abstract
Generative adversarial networks (GANs), introduced by Ian Goodfellow in 2014, have revolutionized adversarial machine learning, particularly in data synthesis. This manuscript explores their application in ophthalmic diagnostics, addressing the scarcity of annotated datasets and the need for improved early disease detection. By leveraging GAN architectures, the goal is to enhance the quality of synthetic ophthalmic images, ultimately improving diagnostic algorithm training. A systematic review was conducted from January to April 2024 across PubMed, Embase, and Scopus. Search terms included "Generative Adversarial Networks" and "ophthalmic image synthesis." Articles were selected based on relevance to retinal image generation and diagnostic improvement in ophthalmology. GANs show considerable promise in generating high-resolution retinal and optical coherence tomography (OCT) images. Models like DR-GAN and Pix2Pix have successfully synthesized images that resemble real diagnostic data, proving valuable when annotated datasets are scarce. GAN-generated images enhance training for algorithms detecting diseases such as diabetic retinopathy, glaucoma, and age-related macular degeneration. Recent advances, including conditional GANs and CycleGANs, have enabled disease-specific image generation, boosting the diversity of training datasets, particularly in resource-limited settings. Integrating GANs into ophthalmic diagnostics represents a significant leap in medical AI, offering…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Learning from First-Generation Qualitative Approaches in the IS Discipline: An Evolutionary View and Some Implications for Authors and Evaluators (PART 1/2)
- Commentary on the clinical and preclinical dosage limits of interstitially administered magnetic fluids for therapeutic hyperthermia based on current practice and efficacy models
- Prosthesis: New Technological Opportunities and Innovative Biomedical Devices
- The history and future of neural modeling for cochlear implants
- Ryanodine receptors: waking up from refractoriness
- Novel Transgenic Rabbit Model Sheds Light on the Puzzling Role of Matrix Metalloproteinase-12 in Atherosclerosis
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.